JNCI-Journal of the National Cancer Institute

简称 JNCI-J NATL CANCER I ·UNITED STATES ·出版周期 Semimonthly ·年均收录 165 篇

7.2

最新影响因子

100.00%

自引率

很难

投稿难度

偏慢,4-8周

审稿周期

期刊简介

JNCI-Journal of the National Cancer Institute是一本专注于癌症研究的学术期刊，ISSN号为0027-8874，由牛津大学出版社出版，出版地为英国，出版周期为月刊。该期刊的影响因子较高，属于SCI收录期刊，在中科院分区中通常位于医学领域的较高分区（如1区或2区），但具体分区需根据每年更新的数据确认。期刊为非开放获取（OA）模式。其发文特点集中于癌症的基础、临床和流行病学研究，涵盖癌症预防、诊断、治疗及分子机制等广泛领域，以高质量原创研究和综述为主。该杂志在学术界享有较高声誉，审稿严格，但投稿竞争激烈，拒稿率较高，可能存在发表周期较长的风险。总体而言，JNCI是癌症研究领域的重要期刊，适合发表具有创新性和影响力的研究成果。

影响因子趋势

近期发表

Writing and reviewing for <i>JNCI</i> 2026-07-30

Re: ‘Advance care planning impact on caregivers and end-of-life care in advanced cancer’ 2026-09-04

Psychological distress in adult patients with colorectal cancer: roles of biological age and neighborhood deprivation 2026-09-04

A phase II randomized study of proton therapy vs intensity-modulated radiation therapy in patients with unilateral head and neck cancer 2026-08-14

Cancer rarity and mortality: Evidence from a nationwide cohort study 2026-09-01

Evaluating the incidence and predictors of chronic opioid use in early survivorship for patients with diffuse large B-cell lymphoma 2026-09-01

Matched targeted therapy use after broad genomic profiling in advanced Non-Small cell lung cancer 2026-09-01

Rising colorectal cancer mortality among young adults in many countries 2026-09-01

Predictive validity of a 10-item frailty index based on a comprehensive geriatric assessment (FI-CGA-10) in older Japanese adults with cancer 2026-08-31

RE: Impact of KRAS codon-specific mutations on survival in metastatic CRC on trifluridine-tipiracil with/without bevacizumab 2026-08-22